Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A study in healthy men to test whether esomeprazole influences the amount of BI 3000202 in the blood Ended

2023-509209-54-00 Healthy volunteer trial 2024-05-21
A Randomized, double-blind, placebo-controlled, three-way cross-over study to assess the pharmacodynamic effects of an authorised and a new … Ended

2024-510721-26-00 neuropathic pain 2024-05-17
A Pharmacokinetics (PK) study to compare GME751 (proposed pembrolizumab biosimilar) and United States (US)-licensed and European Union (EU)-… Ended

2023-506881-30-00 Melanoma 2024-05-15
A Study to find out the safety, tolerability and interaction of drug with body (including the effect of Itraconazole on RO7268489) and also … Ended

2024-510606-85-00 Not applicable 2024-05-10
A study to test how BI 456906 is taken up in the blood of people with and without kidney problems Ended

2023-508557-13-00 Renal impairment (mild, moderate and severe) 2024-05-08
A Multiple-Ascending-Dose Study of MK-1708 in Healthy Participants Ended

2024-511405-27-00 Amyotrophic lateral sclerosis and Alzheimer’s disease 2024-05-08
A study in healthy men and women to test whether BI 1569912 influences the amount of repaglinide, midazolam and bupropion in the blood Ended

2023-510461-10-00 Healthy volunteer trial 2024-05-07
A SINGLE-CENTER, OPEN-LABEL, TWO-PERIOD STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSE ITRACONAZOLE, A STRONG CYP3A INHIBITOR, ON THE PHAR… Ended

2024-510732-52-00 Not applicable, healthy volunteers 2024-05-07
A study to learn about how much emodepside gets absorbed in the blood and how food affects its absorption when given as a new type of tablet… Ended

2023-508905-26-00 Onchocerciasis (river blindness): is an infectious dise 2024-05-06
Safety and tolerability of single and multiple ascending doses of lunsekimig (SAR443765) in healthy participants Ended

2023-509316-28-00 Asthma 2024-05-06
Exploratory study to assess the pharmacokinetic interaction of doxepin with adrenaline after a concomitant co-administration using the Anape… Ended

2023-508117-16-00 Anaphylaxis 2024-05-03
A study to test how well multiple doses of BI 765423 are tolerated by healthy men Ended

2023-506722-36-00 Healthy volunteer trial 2024-04-30
Investigating how CagriSema, semaglutide and cagrilintide regulate insulin effects in the body of people with type 2 diabetes. Ended

2023-509483-20-00 Type 2 diabetes 2024-04-26
The Attractive 2 trial – An open-label, randomised, 2-period cross-over trial to assess the pharmacokinetics of ATR-258 oral capsule vs. ora… Ended

2023-508797-28-00 Type 2 diabetes (T2D) 2024-04-24
A study to investigate the safety, tolerability, and pharmacokinetics of Ent001 in patients with moderately to severely active ulcerative co… Ended

2023-507340-36-00 Inflammatory bowel disease (moderate to severe active u 2024-04-22
Study of excretion of CORTICOSTEROIDS to improve their detection in Anti-doping controls. Ended

2023-508221-27-02 Healthy volunteers 2024-04-19
Open-label single-arm, multicenter clinical trial to evaluate patient acceptability of a new CREON formulation of Pancreas Powder gastro-res… Ended

2023-503256-27-00 patients with cystic fibrosis suffering from pancreatic 2024-04-18
A study in people with overweight or obesity to test how BI 1820237, BI 456906, or a combination of both affects brain activity Ended

2023-506233-30-01 Obesity 2024-04-15
A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin Ended

2023-509339-17-00 Inflammatory bowel disease 2024-04-15
MK-4318 CIDF Target Engagement Study Ended

2023-509645-12-00 Pain 2024-04-12
Phase 1 study in Staphylococcus aureus endocarditis Ended

2023-505413-25-00 Infectious S. aureus endocarditis 2024-04-10
A study to investigate the pharmacokinetics of a combined oral contraceptive when given alone and in combination with GSK3036656 in female p… Ended

2023-507839-38-00 Tuberculosis 2024-04-05
Randomized, crossover, two-period, two-treatment, comparative bioavailability study of ibuprofen (arginine) granules for oral solution, deve… Ended

2023-509219-97-00 Healthy volunteers 2024-04-01
A study in healthy people to test how well different doses of BI 3000202 are tolerated and how they affect the way the body handles midazola… Ended

2023-509293-29-00 Healthy volunteer trial 2024-03-28